---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-253604"
form_type: "8-K"
ticker: "KYTX"
cik: "0001994702"
company_name: "Kyverna Therapeutics, Inc."
filed_at: "2026-06-02T20:30:16+00:00"
generated_at: "2026-06-02T20:35:25.880051+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Kyverna Therapeutics shareholders elect Ian Clark and Christi Shaw as Class II directors, ratify BDO USA auditor

## Summary
- 73% of outstanding shares (43.99M of 60.53M) represented at May 27, 2026 annual meeting, forming quorum.
- Ian Clark elected as Class II director: 31,505,902 for, 3,255,231 withheld, 9,225,874 broker non-votes.
- Christi Shaw elected as Class II director: 34,528,865 for, 232,268 withheld, 9,225,874 broker non-votes.
- BDO USA ratified as independent auditor for FY 2026: 43,830,300 for, 80,223 against, 76,484 abstain.

## SEC filing metadata
- accession: 0001193125-26-253604
- form_type: 8-K
- ticker: KYTX
- cik: 0001994702
- company_name: Kyverna Therapeutics, Inc.
- filed_at: 2026-06-02T20:30:16+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1994702/000119312526253604/0001193125-26-253604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1994702/000119312526253604/kytx-20260527.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-253604
- JSON: https://secwatch.observer/filing/0001193125-26-253604.json
- Plain text: https://secwatch.observer/filing/0001193125-26-253604.txt

## Source-grounded claims
- claim_id: 017e4ce42dcbb485626e089f2682f2b2e19f6666
  claim: Kyverna Therapeutics, Inc. shareholders approved Election of two Class II directors at the 2026-05-27 meeting.
  evidence_excerpt: Director Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 31,505,902 3,255,231 9,225,874 Christi Shaw 34,528,865 232,268 9,225,874
  evidence_url: https://www.sec.gov/Archives/edgar/data/1994702/000119312526253604/0001193125-26-253604-index.htm
- claim_id: 8281828b47cca0b52e27f5087f9d9d926dbf7064
  claim: Kyverna Therapeutics, Inc. shareholders approved Ratification of appointment of BDO USA, P.C. as independent registered public accounting firm at the 2026-05-27 meeting.
  evidence_excerpt: Votes For Votes Against Abstentions 43,830,300 80,223 76,484
  evidence_url: https://www.sec.gov/Archives/edgar/data/1994702/000119312526253604/0001193125-26-253604-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.